Cargando…
A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand
BACKGROUND: To evaluate the effectiveness of intravitreal bevacizumab (IVB) and intravitreal ranibizumab (IVR) in actual practice for treating patients with retinal diseases in Thailand. METHODS: A prospective, multi-centre, observational study was conducted among eight hospitals in their ophthalmol...
Autores principales: | Kumluang, Suthasinee, Ingsrisawang, Lily, Sangroongruangsri, Sermsiri, Chaikledkaew, Usa, Ratanapakorn, Tanapat, Ruamviboonsuk, Paisan, Taweebanjongsin, Wongsiri, Choovuthayakorn, Janejit, Thoongsuwan, Somanus, Hanutsaha, Prut, Kulvichit, Kittisak, Ratanapojnard, Thitiporn, Wongsawad, Warapat, Leelahavarong, Pattara, Teerawattananon, Yot |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439979/ https://www.ncbi.nlm.nih.gov/pubmed/30922350 http://dx.doi.org/10.1186/s12886-019-1086-1 |
Ejemplares similares
-
Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study
por: Sangroongruangsri, Sermsiri, et al.
Publicado: (2018) -
Correction to: Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study
por: Sangroongruangsri, Sermsiri, et al.
Publicado: (2019) -
Cost-Utility Analysis of Drug Treatments in Patients with Polypoidal Choroidal Vasculopathy in Thailand
por: Sangroongruangsri, Sermsiri, et al.
Publicado: (2021) -
Treatment Outcome of Wet Age-Related Macular Degeneration Management in Thailand: A Retrospective Real-World Study (TOWER Study)
por: Thoongsuwan, Somanus, et al.
Publicado: (2022) -
Clinical Correlation of Retinal Fluid Fluctuation Represented by Fluctuation Index in Wet Age-Related Macular Degeneration: TOWER Study Report 2
por: Chantarasorn, Yodpong, et al.
Publicado: (2023)